Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Real-world practice patterns and characteristics of adverse events with selexipag in Korean patients with pulmonary arterial hypertension.

< BACK TO ARCHIVE


2022 Apr 22


Expert Opin Drug Saf


http://www.ncbi.nlm.nih.gov/pubmed/35451909?dopt=Abstract

Real-world practice patterns and characteristics of adverse events with selexipag in Korean patients with pulmonary arterial hypertension.

Authors

Real-world practice patterns and characteristics of adverse events with selexipag in Korean patients with pulmonary arterial hypertension.
Chang S-A, Lee S H, Choi J H, Chung W-J, Choi J Y, Kim H-K, Jung H-O, Park S-M, Kim W-J, Jung S Y, Chang H-J
Expert Opin Drug Saf. 2022 Apr 22.
PMID: 35451909.

Abstract

Optimizing an individual dose with careful management of adverse events (AEs) is essential in the treatment with selexipag approved for pulmonary arterial hypertension (PAH). This study aims to identify real-world practice patterns and AE characteristics of selexipag.
Read This Paper